ANXA4 and breast cancer: In vitro functional analyses showed that forced overexpression of ANXA4 induced carboplatin resistance in OVSAYO SC-cells [11], paclitaxel resistance in 293T cells [22], migration on vitronectin in MCF-7 breast cancer cells [21], and proliferation in AGS gastric cancer cells [16].